Answers are grounded in this paper and cite their sources.
The co-infection of tuberculosis (TB) and human immunodeficiency virus (HIV) poses a major global health challenge. Human leukocyte antigen (HLA) plays a significant role in influencing the outcome of the disease. Several studies have revealed that HLA class II genes, specifically HLA-DRB1 and HLA-DQB1, are linked to TB and HIV infections. Only a few studies have investigated the genotype or allelic frequencies of HLA genes in the co-infection of HIV/TB. In this study, the mRNA expression of DRB1*15:01:01, DQB1*06:02:01:01, CD4, and IFNγ was determined in participants with mono-infection of HIV-1 (n = 28), mono-infection of TB (n = 31), and co-infection of HIV-1/TB (n = 21) and compared with healthy controls (n = 20). The relative quantification of the transcripts was determined using an RT2-Profiler PCR array. The findings revealed a significantly higher expression of the HLA-DRB1 gene, with a fold change of 3.7 (p = 0.005), in individuals with TB infection alone. In contrast, expression of the HLA-DQB1 gene was significantly decreased by 1.3-fold change (p = 0.008) in individuals with HIV-1/TB co-infection. Additionally, the mRNA expression of CD4 was elevated (fc: 1.2, p = 0.94) in the TB group, whereas in the HIV-1 and HIV-1/TB groups, there was a decrease in CD4 mRNA expression (HIV: fc −1.3, p = 0.045) (HIV-1/TB: fc −1.15, p = 0.191). In contrast, IFNγ mRNA expression was decreased in TB but relatively higher in individuals with HIV-1 and HIV-1/TB co-infection. We further evaluated the correlation between CD4 and IFNγ mRNA expression in all three groups. We found a significant negative correlation (TB: r = −0.386, HIV-1: r = −0.498, p < 0.05) between CD4 and IFNγ in the TB and HIV-1 groups, while a positive correlation was observed in the HIV-1/TB group (r = 0.330, p > 0.05). A decrease in HLA-DQB1 and CD4 mRNA expression and an increase in IFNγ in HIV/TB co-infection suggests that these markers are involved in the immunopathogenesis and progression of the disease.
No takes yet. Share an insight, caveat, or question.
Shaukat et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: